CAPN3 gene therapy (Nationwide Children’s Hospital)

N/A

Report date: 2025/01/26 18:59:28

Base Information

Drug NameCAPN3 gene therapy (Nationwide Children’s Hospital)
Drug Alias NameCalpain 3CAPN3 gene therapy (Nationwide Children’s Hospital)CAPN-3
ClassificationBiologics
Mechanisms of ActionCalpain-3 stimulants
TargetsCalpain-3
Therapy Area/IndicationsMuscular Dystrophies, Limb-Girdle
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNationwide Children'S Hospital
China Registration ClassN/A

Develop Information

Active CompaniesSarepta Therapeutics Inc
Active IndicationsMuscular Dystrophies, Limb-Girdle
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A